IPO Trending
AAKAARSME / NSEListed
Aakaar Medical Technologies

Aakaar Medical Technologies Limited, established in June 2013, is a company focused on aesthetic medical solutions, offering a wide range of specialized cosmetic products and devices. It primarily caters to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. The company provides both its own brands—comprising products made in India and devices produced internationally—as well as imported brands from countries like South Korea, Spain, Italy, and Austria. These products are mainly supplied to professionals who either use them during treatments or sell them to end users. Aakaar’s offerings include skincare for home and professional use, injectable and contouring products, hair care solutions such as growth serums and tablets, medifacial kits, and various medical devices. These devices are used for treatments like urinary incontinence, tattoo removal, skin rejuvenation, laser hair reduction, and hair transplants. With a presence across India, the company has a strong network of 90 trained sales and service engineers, supporting a large and satisfied customer base. It distributes its products in multiple states including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.

₹68 - ₹722.25x sub
Listed Price₹75.00
Listing Gain+4.17%

Subscription Status

2.25xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB3.51x
Popular / Warm DemandOffered: 7,12,000 sh
Nib1.43x
Fully Subscribed (Safe)Offered: 6,04,400 sh
Retail1.93x
Fully Subscribed (Safe)Offered: 12,48,000 sh
CategoryOfferedAppliedTimes
QIB7,12,00024,96,0003.51x
Nib6,04,4008,63,6001.43x
Retail12,48,00024,11,2001.93x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB17.975.133.50x
Retail17.368.991.93x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
QIB07Open
Nib0123Open
Retail01,507Open
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Aakaar Medical Technologies IPO Subscription Demand

Live subscription status and bidding analysis for Aakaar Medical Technologies (AAKAAR) IPO. The issue is subscribed 2.25x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions